Strides Pharma Science reports consolidated net profit of Rs 46.09 crore in the March 2021 quarter

Sales rise 46.85% to Rs 908.49 crore

Net profit of Strides Pharma Science reported to Rs 46.09 crore in the quarter ended March 2021 as against net loss of Rs 203.93 crore during the previous quarter ended March 2020. Sales rose 46.85% to Rs 908.49 crore in the quarter ended March 2021 as against Rs 618.64 crore during the previous quarter ended March 2020.

For the full year,net profit rose 637.68% to Rs 268.44 crore in the year ended March 2021 as against Rs 36.39 crore during the previous year ended March 2020. Sales rose 20.49% to Rs 3315.87 crore in the year ended March 2021 as against Rs 2751.97 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales908.49618.64 47 3315.872751.97 20 OPM %15.033.27 -16.2014.39 - PBDT108.02-1.60 LP 452.32293.30 54 PBT56.16-46.94 LP 246.03119.60 106 NP46.09-203.93 LP 268.4436.39 638

Powered by Capital Market - Live News